Sign in

Matthias Löhr ʚїɞ

@maloehr.bsky.social
489 followers 145 following 183 posts

Professor of Gastroenterology at #Karolinska Institutet. #Pancreas lover.

PostsRepliesMedia
Reposted by Matthias Löhr ʚїɞ
The Lancet @thelancet.com · 23/07/2026
🔔 Discover The Lancet Surgery & Anaesthesiology, a new journal with a sharp clinical focus, dedicated to advancing science across the full extent of #surgery, #anaesthesiology, and #perioperative specialties, across the age spectrum, and across the globe: spkl.io/633237JQbc
Illustration of a female in green scrubs, cap, and blue surgical mask, surrounded by four smaller illustrations showing surgical instruments and operating room scenes. Copyright: Grace Russell.
1710
Reposted by Matthias Löhr ʚїɞ
Let's Win Pancreatic Cancer @letswinpc.org · 16/07/2026
Who is high-risk for pancreatic cancer? Oncologist Dr. Matthew Yurgelun explains high-risk populations and what steps to take if you meet the criteria. bit.ly/3r82KSD
bit.ly
Understanding Who Is at High Risk for Pancreatic Cancer
Who is high-risk for pancreatic cancer? Oncologist Dr. Matthew Yurgelun explains high-risk populations and what steps to take if you meet the criteria.
011
Reposted by Matthias Löhr ʚїɞ
Eric Topol @erictopol.bsky.social · 16/07/2026
This is big. The first vaccine tested to PREVENT pancreatic cancer in high-risk individuals aacrjournals.org/cancerdiscov...
aacrjournals.org
First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts
Abstract. Pancreatic ductal adenocarcinoma (PDAC) arises from precursor lesions over a decade-plus, offering a window for interception in high-risk individuals, but current surveillance detects a mino...
7837131121
Reposted by Matthias Löhr ʚїɞ
STITCHES Medicine - the Best of Medical Research @medicine.stitches.today · 14/07/2026
Pancreatic neck margin testing offers no survival benefit in pancreatic cancer surgery, highlighting need for clearer clinical guidelines. by Woo KP, Bennett WC (...) Naffouje SA et 13 al. in Ann Surg Oncol #MedSky 👉 get more here 📖 read the article:
link.springer.com
The Practices of Pancreatic Neck Margin Testing and Their Outcomes after Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma - Annals of Surgical Oncology
Background The role of checking the pancreatic neck margin with frozen section (PNM-FS) during pancreatoduodenectomy (PD) for pancreatic ductal adenocarcinoma (PDAC) to secure R0 resection and its impact on long-term outcomes remains an area of debate. Patients and Methods Patients with PD for PDAC between 2018 and 2023 were included. The primary outcome was pancreatic neck recurrence-free survival (PN-RFS). Secondary outcomes were locoregional recurrence-free survival (LR-RFS), distant recurrence-free survival (D-RFS), and overall survival (OS). Results There were 403 patients who met inclusion criteria. PNM-FS was checked in 361 patients (89.6.2%) and returned negative at first attempt in 285 (78.9%). A total of 76 patients had positive PNM-FS; 71 were revised and clearance achieved on repeat sampling in 49 (69.0%). Median PN-RFS in patients with PNM-FS cleared with revision was significantly shorter compared with those with negative PNM-FS at first attempt (16.9 versus 23.1 months; p = 0.048) but was not different from patients with PNM-FS not cleared (16.9 versus 16.0 months; p = 0.961). LR-RFS and D-RFS were not different between the groups. OS was marginally longer in patients with negative PNM-FS at first attempt (23.9 versus 19.4 versus 16.0 months; p = 0.049). Six patients underwent completion total pancreatectomy (TP) for margin clearance, four developed distant recurrence, one locoregional recurrence and two died without disease at 1 and 11 months postoperatively. Conclusions PNM-FS is only a prognostic marker. Pursuing PNM-FS clearance does not improve PN-RFS, LR-RFS, D-RFS, or OS. Furthermore, pursuing a completion TP may be associated with shorter OS either from disease progression or surgical morbidity.
031
Reposted by Matthias Löhr ʚїɞ
Pancreatic Cancer Europe @pce-europe.bsky.social · 14/07/2026
🔎 Know the Symptoms of Pancreatic Cancer Losing weight without trying? Unexplained weight loss is an important warning sign that should not be ignored. Learn the 10 warning signs: pancreaticcancereurope.eu/wp-conten…
021
Reposted by Matthias Löhr ʚїɞ
Karolinska Institutet @ki.se · 14/07/2026
A new study in Journal of Experimental & Clinical Cancer Research shows that sodium selenite can reinforce epithelial features and dampen EMT-associated plasticity in pancreatic cancer. The effect was dose- and context-dependent in patient-derived tissues. #PancreaticCancer 🧪
131
Reposted by Matthias Löhr ʚїɞ
United European Gastroenterology @myueg.bsky.social · 10/07/2026
🎯 #FIT and #colonoscopy provide comparable #ColorectalCancer screening outcomes across sex & age groups 🔸 FIT → higher participation 🔸 Similar CRC incidence & mortality reduction 🔸 Colonoscopy detected more premalignant lesions Learn more in UEG Journal: 👉 bit.ly/3RDSXR0
Eine Infografik, die Kolonoskopie und den immunochemischen Test für die Früherkennung von Darmkrebs vergleicht und die geschlechtsspezifischen und altersabhängigen Unterschiede zeigt.
011
Reposted by Matthias Löhr ʚїɞ
United European Gastroenterology @myueg.bsky.social · 03/07/2026
🦠 #PancreaticCancer is linked to distinct oral & duodenal #microbiome signatures 🔸↓Duodenal microbial diversity in #PDAC 🔸Oral-duodenal taxa overlap supports microbial migration 🔸Higher salivary diversity → longer survival Access the article in UEG Journal: 👉 bit.ly/3RlQomF
Das Bild zeigt eine detaillierte Darstellung der menschlichen Anatomie des Verdauungssystems, einschließlich des Pankreas, des Zwölffingerdarms und der Speicheldrüsen, zusammen mit Grafiken zur Überlebensrate bei Bauchspeicheldrüsenkrebs.
021
Reposted by Matthias Löhr ʚїɞ
Pancreatic Cancer Europe @pce-europe.bsky.social · 16/06/2026
🔎 Know the Symptoms of Pancreatic Cancer Recently diagnosed with diabetes and not sure why? In some cases, new-onset diabetes can be linked to pancreatic cancer. Learn the 10 warning signs: pancreaticcancereurope.eu/wp-conten…
021
Reposted by Matthias Löhr ʚїɞ
Lesley Goodburn @lgoodbu.bsky.social · 11/06/2026
www.sciencedirect.com/science/arti...
sciencedirect.com
Dec2 conceals tumors from the immune system
In this issue of Developmental Cell, Wang et al. establish a murine resectable pancreatic ductal adenocarcinoma (PDAC) model and identify circadian re…
011
Reposted by Matthias Löhr ʚїɞ
Deutsches Krebsforschungszentrum (DKFZ) @dkfz.bsky.social · 12/06/2026
Morgen startet die Aktionswoche Alkohol - unterstützt durch die Stabsstelle #Krebsprävention des DKFZ. Sie lädt dazu ein, sich mit #Alkohol und Alkoholkonsum kritisch auseinanderzusetzen. Hier gibt es wissenschaftlich fundierte Informationsmaterialien: t1p.de/80guf @bdb-offiziell.bsky.social
021
Matthias Löhr ʚїɞ @maloehr.bsky.social · 12/06/2026
Same as we reached within #PANCAIM @euprojectpulse.bsky.social project with the #grandchallenge #PANORAMA study! Read our piece in @thelancet.com
011
Reposted by Matthias Löhr ʚїɞ
NEJM.org @nejm.org · 03/06/2026
In a phase 3 trial, obexelimab led to a lower risk of disease flares than placebo among patients with IgG4-related disease. Glucocorticoid use was lower and the incidence of remission was higher with obexelimab than with placebo. Full INDIGO trial results: nej.md/4fKYQG4 #EULAR2026
A line graph from an article titled "Obexelimab for the Treatment of IgG4-Related Disease," which shows estimates over time of the probability of a first flare of IgG4-related disease for which rescue therapy was required. Below the graph is a footnote detail and the logo for the New England Journal of Medicine.
091
Reposted by Matthias Löhr ʚїɞ
Let's Win Pancreatic Cancer @letswinpc.org · 03/06/2026
Daraxonrasib, the first KRAS drug for pancreatic cancer, is now available through an expanded access program, but your physician must apply for you. bit.ly/4uWZ9C5 #OncSky
bit.ly
Accessing Daraxonrasib: A Quick Primer
Daraxonrasib, the first KRAS drug for pancreatic cancer, is now available through an expanded access program.
052
Matthias Löhr ʚїɞ @maloehr.bsky.social · 03/06/2026
Story #1 is message #1 @pancreaticcancer
000
Reposted by Matthias Löhr ʚїɞ
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 21/05/2026
ICYMI: New online! Identifying MASLD patient eligibility for pharmacological therapy: the need to integrate evidence into clinical practice
dlvr.it
Identifying MASLD patient eligibility for pharmacological therapy: the need to integrate evidence into clinical practice
Nature Reviews Gastroenterology & Hepatology, Published online: 20 May 2026; doi:10.1038/s41575-026-01214-8Metabolic dysfunction-associated steatotic liver disease is a leading cause of chronic liver disease, with rising liver transplantation rates. New therapies such as resmetirom and semaglutide mark a shift in treatment. However, identifying suitable patients remains challenging, requiring integrated approaches combining fibrosis stage, metabolic factors and non-invasive tools in real-world practice.
032
Reposted by Matthias Löhr ʚїɞ
United European Gastroenterology @myueg.bsky.social · 22/05/2026
Screening can help reverse the rising trend of digestive cancers across Europe – but only if it reaches everyone. Zorana Maravic from @digestivecancerseu.bsky.social​ calls for urgent action to raise awareness, increase uptake & close the access gap: bit.ly/4mYFleR #DigestiveHealthMonth
The image shows a smiling woman with blonde hair, wearing a black top, against a dark background with text indicating "Digestive Health Month 2026" and "Zorana Maravic, CEO of DiCE".The image shows various colorful, abstract shapes representing internal organs, with text describing the importance of early detection for digestive cancers and the goal of raising awareness and increasing screening access across Europe.
023
Reposted by Matthias Löhr ʚїɞ
United European Gastroenterology @myueg.bsky.social · 22/05/2026
Did you know Gutflix has bookmarks? 🔖 Build your 'study later' list 🔖 Pick up where you left off 🔖 Save what matters to your practice Bookmark your favourite content today: gutflix.eu
The image displays the Gutflix platform's user interface, featuring two content thumbnails labeled "Consequences of proctology surgery (LARS)" and "GORD Pathophysiology - Part 2".The image shows the Gutflix website interface, with options to visit the website, manage bookmarks, view recommendations, fields of interest, and log out.The image shows a black background with the text "gutflix" in large green letters, along with three bullet points describing how bookmarks can help a user build their "study later" list, pick up where they left off, and save what matters to their practice.
011
Matthias Löhr ʚїɞ @maloehr.bsky.social · 16/05/2026
Demonstrating one more time the importance of the #centralorgan So-called “sympathetic” reaction
010
Matthias Löhr ʚїɞ @maloehr.bsky.social · 16/05/2026
Very nice review by world renowned experts!
020
Matthias Löhr ʚїɞ @maloehr.bsky.social · 16/05/2026
Excellent Chance to raise your Level of Expertise and increase your Network!
011
Reposted by Matthias Löhr ʚїɞ
European Research Council (ERC) @erc.europa.eu · 14/05/2026
Are you a researcher based in the USA 🇺🇸 or Canada 🇨🇦 interested in pursuing curiosity-driven research in Europe? Join the ERC and Euraxess for a webinar exploring ERC funding opportunities. 👇️ 📅 20 May 2026 🕚 11:30 AM ET | 8:30 AM PT 💻 Online Find out more and register:
buff.ly
ERC Grants Info Session: Funding for Excellent Frontier Research
Join EURAXESS North America and the European Research Council Executive Agency for a webinar on the bottom-up funding schemes that make up the European Research Council grants. The ERC is the premier…
01416
Reposted by Matthias Löhr ʚїɞ
Pancreatic Cancer Europe @pce-europe.bsky.social · 12/05/2026
🟣 Did you know? Your pancreas produces about 1.5 litres of digestive juices every day to help break down proteins, fats, and carbohydrates in your food. This powerful little organ is working hard behind the scenes every time you eat. 🔗 Learn more: pancreaticcancereurope.eu
032
Reposted by Matthias Löhr ʚїɞ
Pancreatic Cancer Europe @pce-europe.bsky.social · 08/05/2026
Yesterday at the #DISCERN Annual Meeting, PCE Chairperson Alfredo Carrato joined a roundtable on patient advocacy in cancer research. The message was clear: clinical trials must meet patients where they are, emotionally and humanly. Patient voice isn't commentary, it's evidence.
011
Matthias Löhr ʚїɞ @maloehr.bsky.social · 09/05/2026
A wuestion asked by patients and to be answer by doctors … @pancaid.bsky.social
000
Matthias Löhr ʚїɞ @maloehr.bsky.social · 08/05/2026
Most of the work 📄 eventually being awarded with a #nobelprize was done by scientists 👩‍🔬 in their thirties
010
Reposted by Matthias Löhr ʚїɞ
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 07/05/2026
ICYMI: New online! Cirrhosis, portal hypertension and hepatocellular carcinoma: a stage-based approach
dlvr.it
Cirrhosis, portal hypertension and hepatocellular carcinoma: a stage-based approach
Nature Reviews Gastroenterology & Hepatology, Published online: 06 May 2026; doi:10.1038/s41575-026-01209-5Cirrhosis, portal hypertension and hepatocellular carcinoma (HCC) are interconnected but are often addressed separately. This Review outlines the key interactions between portal hypertension and HCC in cirrhosis, and explores the management of these conditions across all stages, proposing an integrated, stage-based management framework.
031
Reposted by Matthias Löhr ʚїɞ
United European Gastroenterology @myueg.bsky.social · 08/05/2026
👩‍👧Maternal #MASLD increases risk of serious infections in offspring Swedish nationwide cohort: 🔸 Overall risk ↑ (aHR 1.81) 🔸 Highest in infancy (aHR 3.11) 🔸 Risk persists up to 31 yrs Read the article in UEG Journal: 👉 bit.ly/4uhhWYC
Eine Infografik zeigt Informationen zur erhöhten Infektionsrisiken bei Kindern von Müttern mit einer bestimmten Lebererkrankung.
011
Reposted by Matthias Löhr ʚїɞ
United European Gastroenterology @myueg.bsky.social · 08/05/2026
Reducing digestive cancer mortality starts even before treatment – with stronger prevention and screening. Hear from Thomas Seufferlein from ESDO on the key actions needed to move digestive cancer prevention forward 👉 bit.ly/4mYFleR #DigestiveHealthMonth #EUNewsline
The image shows a middle-aged man with gray hair and glasses, wearing a white collared shirt, and smiling at the camera against a blurred background.The image displays text titled "Digestive Health Month 2026" and a quote by Thomas Seufferlein, ESDO Secretary General & UEG Public Affairs Group Member, discussing the importance of prioritizing prevention and early detection of digestive cancers across Europe.
022
Reposted by Matthias Löhr ʚїɞ
United European Gastroenterology @myueg.bsky.social · 05/05/2026
📊 Digestive diseases and cancers place significant pressure on public health systems and economies across Europe, with findings from the White Book 2 showing that incidence, prevalence and mortality rates have been rising since 2000. Further insights in the thread below ⬇️
The image provides information about a 17% increase in incident cases of digestive diseases between 2000 and 2019.The image shows text that states there has been a 26% increase in incident cases of the most common digestive cancers between 2000 and 2019.
142
Matthias Löhr ʚїɞ @maloehr.bsky.social · 03/05/2026
Wry important! See also #PANCAIM publication of #PANORAMA study led by @radboudumc.bsky.social and @ki.se published in @thelancet.com
000
Reposted by Matthias Löhr ʚїɞ
Seifert Lab @seifertlab.bsky.social · 03/05/2026
New publication in @annsurgoncology.bsky.social! 🎉 We show that low preoperative sCD40 serum levels are significantly associated with key complications after #PancreaticSurgery. 📄 Read the full paper here: link.springer.com/article/10.1... #ClinicalResearch #Surgery #RiskPrediction
011
Matthias Löhr ʚїɞ @maloehr.bsky.social · 03/05/2026
Very important to raise that level!
021
Reposted by Matthias Löhr ʚїɞ
United European Gastroenterology @myueg.bsky.social · 01/05/2026
⚠️Motorized #SpiralEnteroscopy shows higher risk vs #BalloonEnteroscopy Based on >12,500 procedures across 68 studies: 🔸Adverse events: 10.8% vs 1.6% 🔸Serious adverse events: 1.5% vs 0.4% 🔸More esophageal injury & perforation Read the full article in UEG Journal: 👉 bit.ly/4caHVut
The image shows a diagram and statistical information related to the safety of motorized spiral enteroscopy, a medical procedure, including details on adverse events and comparisons to double/single balloon enteroscopies.
011
Reposted by Matthias Löhr ʚїɞ
United European Gastroenterology @myueg.bsky.social · 01/05/2026
#DigestiveHealthMonth starts today 💚 This May, we’re putting prevention front and centre: tackling digestive diseases and cancers through the lens of nutrition and digestive cancer screening 🥗🔍 Find out more and follow along 👉 bit.ly/4iN57Ps #EUNewsline
The image shows a green, plush stuffed animal resembling a reptile or amphibian, surrounded by blue and green spheres or eggs against a dark background.
032
Reposted by Matthias Löhr ʚїɞ
United European Gastroenterology @myueg.bsky.social · 01/05/2026
One EU plan. Two major health challenges. But what does the EU Safe Hearts Plan have to do with digestive health? Join our 7 May webinar to connect the dots – and uncover shared opportunities for prevention 🌍 Register 👉 bit.ly/4tYNGBB
The image shows information about an upcoming webinar hosted by the United Ecologists Group (UEG) on the topic of "Healthy hearts, healthy guts" and how the EU Safe Hearts Plan can improve digestive health.
111
Reposted by Matthias Löhr ʚїɞ
Nature @nature.com · 01/05/2026
🚨🚨 Good news alert! 🚨🚨 We've rounded up five inspiring science stories – including the discovery of a new species, and a promising medical treatment for a fatal mitochondria disease. go.nature.com/4d0b1vG
go.nature.com
The news is not all bad: Five inspiring science stories to lift your mood
Species recovery, cancer-preventing vaccines and progress in developing renewable-energy sources are just some of the positive developments that have happened this year so far.
16124
Reposted by Matthias Löhr ʚїɞ
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 28/04/2026
ICYMI: New online! γδ T cells in colorectal and liver cancer
dlvr.it
γδ T cells in colorectal and liver cancer
Nature Reviews Gastroenterology & Hepatology, Published online: 22 April 2026; doi:10.1038/s41575-026-01196-7γδ T cells are an important component of local immune surveillance. This Review discusses their role in colorectal cancer and hepatocellular carcinoma development and provides a detailed overview of their therapeutic potential.
032
Matthias Löhr ʚїɞ @maloehr.bsky.social · 28/04/2026
Raising awareness for #pancreaticcancer during #masterclass held by @pce-europe.bsky.social in #Malta, sponsored by the Ministry of Health #JoEtienneAbela @nuriamalats.bsky.social
011
Reposted by Matthias Löhr ʚїɞ
Lesley Goodburn @lgoodbu.bsky.social · 23/04/2026
www.roswellpark.org/newsroom/202...
roswellpark.org
New Research Sheds Light on How Precancerous Lesions Form in the Pancreas
Research is significant for future prevention and early detection of pancreatic cancer
011
Reposted by Matthias Löhr ʚїɞ
Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · 23/04/2026
ICYMI: New online! The critical role of gut–brain signalling in eating behaviour and obesity
dlvr.it
The critical role of gut–brain signalling in eating behaviour and obesity
Nature Reviews Gastroenterology & Hepatology, Published online: 21 April 2026; doi:10.1038/s41575-026-01203-xThis Review outlines the role of gut–brain signalling in eating behaviour and obesity, highlighting gut-derived signals and cues relevant during eating phases. Underlying mechanisms of this gut–brain communication are discussed alongside the key role of the vagus nerve in this process.
031
Matthias Löhr ʚїɞ @maloehr.bsky.social · 23/04/2026
An honor to be Part of it!
021
Reposted by Matthias Löhr ʚїɞ
JAMA @jama.com · 23/04/2026
Viktor Ahlqvist, PhD, from the Karolinska Institutet joins JAMA+ AI Associate Editor Yulin Hswen, ScD, MPH, to discuss why automated drug safety surveillance during #pregnancy is urgently needed and how #AI and #computation can strengthen or undermine causal inference.
jamanetwork.com
AI Drug Safety in Pregnancy
JAMA and JAMA+ AI Associate Editor Yulin Hswen, ScD, MPH, spoke with Viktor H. Ahlqvist, PhD, a postdoctoral fellow in the Unit of Integrative Epidemiology of the Institute of Environmental Medicine a...
052
Reposted by Matthias Löhr ʚїɞ
Karolinska Institutet @ki.se · 17/04/2026
Addressing iron status may be relevant for #dementia prevention and healthy #ageing, suggests a KI study published in BMC Medicine @bmc.springernature.com. Both absolute and functional iron deficiency were linked to higher dementia risk in older adults. 🧪 #aging doi.org/10.1186/s129...
doi.org
Iron deficiency and dementia risk: evidence from the Swedish population-based cohort study AMORIS - BMC Medicine
Background Iron deficiency (ID) is proposed to be involved in cognitive aging and dementia; however, empirical data is lacking to support this hypothesis. We examined the association between absolute and functional ID and incident dementia diagnosis. Methods Data from 70,935 individuals aged ≥ 50 years from the Swedish AMORIS cohort, who had blood measurements indicative of iron status between 1985–1996, were used. Participants were followed for incident dementia diagnosis recorded in National Patient Register (inpatient and specialist outpatient) and Prescribed Drug Register (dispensed anti-dementia drugs) for up to 15 years. Two exposure groups were defined: absolute iron deficiency (serum ferritin < 30 ug/L) and functional iron deficiency (transferrin saturation < 20% and serum ferritin ≥ 30 ug/L). The reference group included individuals with measurements in the normal range of hemoglobin, serum iron, and total iron binding capacity. Results A total of 4,994 individuals received a dementia diagnosis over a mean of 12.6 years. Compared with the reference group, absolute and functional ID was associated with increased dementia diagnosis (adjusted hazard ratio (HR) = 1.24, 95% confidence interval (CI): 1.18–1.42; HR = 1.21, 95% CI: 1.05–1.39, respectively), after adjusting for age, sex, education, and comorbidities. The associations were essentially consistent across subgroups, and when further adjusting for kidney function, body mass index, and smoking in subsamples. Conclusions Even though absolute and functional iron deficiency has different underlying mechanisms, we found that both conditions are associated with an increased risk of dementia. Considering that iron deficiency is a pervasive but often neglected health issue in older adults, resolving iron deficiency may be relevant for dementia prevention.
053
Matthias Löhr ʚїɞ @maloehr.bsky.social · 17/04/2026
💡 Pancreatic exocrine insufficiency (PEI) is common, yet frequently unrecognised. PEI is a common driver of malnutrition. PEI is a maldigestion syndrome that demands a structured, context-driven approach. @myueg.bsky.social 🔗 Access the full article on Gutflix: bit.ly/4mDbeJF
bit.ly
Mistakes in Pancreatic exocrine insufficiency and how to avoid them
Pancreatic exocrine insufficiency (PEI) is a common yet frequently under-recognised cause of maldigestion, malabsorption, and malnutrition. Although traditio...
010
Reposted by Matthias Löhr ʚїɞ
PANCAID @pancaid.bsky.social · 13/04/2026
Detecting cancer early can dramatically improve outcomes. This week's glossary carousel explains: • Diagnosis • Screening • Early detection These concepts are central to ongoing research aimed at improving survival rates for pancreatic cancer. #EarlyDetection #CancerAwareness #PancreaticCancer
021
Matthias Löhr ʚїɞ @maloehr.bsky.social · 12/04/2026
Following the #guidelines for #pancreaticexocrineinsufficiency supported by @myueg.bsky.social @uegj.bsky.social , we put together a review covering the important aspects, now published in a @elsevierconnect.bsky.social journal, @eclinicalmed.bsky.social authors.elsevier.com/sd/article/S...
authors.elsevier.com
ScienceDirect.com | Science, health and medical journals, full text articles and books.
010
Reposted by Matthias Löhr ʚїɞ
Lesley Goodburn @lgoodbu.bsky.social · 12/04/2026
medicalxpress.com/news/2026-04...
medicalxpress.com
Reprogramming regulatory T cells could help immunotherapy work in pancreatic cancer
Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in pancreatic cancer—and identified a promising strategy to overcome that resistance....
011
Reposted by Matthias Löhr ʚїɞ
United European Gastroenterology @myueg.bsky.social · 10/04/2026
🥗 Sucrase-isomaltase variants do not influence #FODMAP diet outcomes in #IBS 🔸 54% carried ≥1 hypomorphic SI variant 🔸 Initial & long-term diet response similar across genotypes 🔸 Dietary intake unaffected by carrier status Read more in UEG Journal: 👉 bit.ly/4vhwxoj
021
Matthias Löhr ʚїɞ @maloehr.bsky.social · 11/04/2026
This is the way to go! As we are doing w/ @pancaid.bsky.social
022